Literature DB >> 25608125

Clinical, imagiological and etiological spectrum of posterior reversible encephalopathy syndrome.

P Ricardo Pereira1, João Pinho2, Margarida Rodrigues2, João Rocha2, Filipa Sousa2, José Amorim3, Manuel Ribeiro3, Jaime Rocha3, Carla Ferreira2.   

Abstract

OBJECTIVE: Analyze the cases of posterior reversible encephalopathy syndrome (PRES) admitted in a Neurology Department during an 8-year period.
METHOD: Retrospective observational study in a central hospital in the north of Portugal.
RESULTS: 14 patients were identified, mean age 52.3 years. Precipitating factors included: eclampsia, isolated arterial hypertension, spinal trauma and autonomic dysreflexia, Guillain-Barré syndrome, sepsis, sarcoidosis and pulmonary cryptococcosis and drugs. Most patients presented posterior-predominant vasogenic edema lesions, however 64.2% presented frontal lesions and in 42.8% cerebellum was involved. Four patients also had acute ischemic lesions and 1 had hemorrhagic lesions. During follow-up 10 patients recovered fully, 2 recovered partially, 1 suffered a recurrence and 2 died in hospital.
CONCLUSION: PRES has many etiological factors. The terms posterior and reversible should be revised because PRES frequently involves other brain regions and it is not always reversible. PRES patients may develop life-threatening complications and mortality is not negligible.

Entities:  

Mesh:

Year:  2015        PMID: 25608125     DOI: 10.1590/0004-282X20140176

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  6 in total

1.  Posterior reversible encephalopathy syndrome in malignant hypertension secondary to focal segmental glomerulosclerosis.

Authors:  Hafez Mohammad Ammar Abdullah; Waqas Ullah; Ejaz Ahmad; Faiz Anwer
Journal:  BMJ Case Rep       Date:  2016-08-17

Review 2.  Atypical presentation of posterior reversible encephalopathy syndrome: Clinical and radiological characteristics in eclamptic patients.

Authors:  Aleksandra Aracki-Trenkić; Dragan Stojanov; Milan Trenkić; Zoran Radovanović; Jelena Ignjatović; Saša Ristić; Marija Trenkić-Bozinović
Journal:  Bosn J Basic Med Sci       Date:  2016-06-20       Impact factor: 3.363

3.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

4.  Posterior reversible encephalopathy syndrome in a woman with focal segmental glomerulosclerosis.

Authors:  Mudit Chowdhary; Ahmad A Kabbani; Devon Tobey; Thomas D Hope
Journal:  Neuropsychiatr Dis Treat       Date:  2015-04-21       Impact factor: 2.570

5.  Posterior reversible encephalopathy syndrome following immunoglobulin therapy in a patient with Miller-Fisher syndrome.

Authors:  Bruno Niemeyer de Freitas Ribeiro; Tiago Medina Salata; Rafael Silveira Borges; Edson Marchiori
Journal:  Radiol Bras       Date:  2016 Jan-Feb

6.  Prevalence and Risk Factors of Posterior Reversible Encephalopathy Syndrome in Isfahan, Iran.

Authors:  Behnaz Ansari; Mohammad Saadatnia
Journal:  Adv Biomed Res       Date:  2021-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.